The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

FDA has ordered specialty pharmacies and online companies to phase out knockoff versions of Eli Lilly blockbuster drugs ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

In a groundbreaking move, the US Food and Drug Administration (FDA) has approved the anti-diabetic drug Zepbound, also known ...

The result: The United Nations says that, at best, it will be able to raise enough money to help about 60% of the 307 million people it predicts will need humanitarian aid next year. That means at ...

The US Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over.

Rep. Diana DeGette is again searching for a Republican co-champion to help take a second swing at passing a second iteration ...

With the help of “Zepbound,” a weight loss injectable with the same active ingredient as Mounjaro, tirzepatide, he lost about ...

Around the holidays, when many people are baking cookies for Santa, enjoying cocktail parties or having festive family feasts ...

The S&P 500 was up 0.7%, with nearly 400 of its stocks on the rise. The Nasdaq Composite was up 0.9%. While tech led the way at the open, all 11 S&P 500 sectors were rising shortly before 11 a.m.